Literature DB >> 5017240

Hyporeninemic hypertension.

M G Crane, J J Harris, V J Johns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5017240     DOI： 10.1016/0002-9343(72)90036-8

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  22 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  [Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion].

Authors:  F Klumpp; D Klaus; R Lemke; J Zehner; P Zöfel
Journal:  Klin Wochenschr       Date:  1975-03-01

3.  Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects.

Authors:  J Genest; R Boucher; O Kuchel; J M Rojo-Ortega; W Nowaczynski
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

4.  A practical approach to hypertension.

Authors:  A Dodek; G Wilkins
Journal:  Can Fam Physician       Date:  1976-12       Impact factor: 3.275

5.  Aldosterone to renin ratio as a predictor of diuretic response.

Authors:  Steven A Atlas
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

6.  Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system.

Authors:  C Kraatz; G Benker; F Weber; D Lüdecke; H Hirche; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-06-19

7.  [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].

Authors:  A Helber; K A Meurer; E Rosskamp; G Wambach; H A Dickmans; W Kaufmann
Journal:  Klin Wochenschr       Date:  1974-10-15

8.  [Antihypertensive effect of spironolactone (author's transl)].

Authors:  H Liebau; W Jarosch-von Schweder
Journal:  Klin Wochenschr       Date:  1974-09-01

Review 9.  Antihypertensive treatment according to age, plasma renin and race.

Authors:  F R Bühler
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

10.  Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.

Authors:  B I Hoffbrand; C J Edmonds; T Smith
Journal:  Br Med J       Date:  1976-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.